TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2026
Voltar para busca
Dado oficial do USPTO
MINARIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MINARIS
ST13
US500000090030815Classe
40, 42, 44
Pedido
90030815
Registro
6799894
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
08/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
40, 42, 44
Data de depósito
01/07/2020
Data de registro
26/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/07/2022
Última transação
08/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
29
Localização do titular
KANAGAWA, JP
Examinador
STRUCK,ROBERT J
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MINARIS REGENERATIVE MEDICINE CO., LTD.
R. C. (pessoa física)
SHOWA DENKO MATERIALS CO., LTD.
HITACHI CHEMICAL COMPANY, LTD.
Representantes
KATE SHERLOCK ARCHER & GREINER, P.C.
Classificação técnica
Classes Nice
Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Contract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; informationadvice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapieshematopoietic and immune system cellsgenetically or otherwise modified cellscells which are propagatedcultivated and expanded in bioreactorscells for the purpose of tissue regeneration
Classe 42
quality control services in the field of cell culture and tissue cultureconsultancy relating thereto; quality control of cell and living tissue for others; Pharmaceutical research and development servicescontracted cell culturing and tissue culturing for scientific purposes; scientific and technological servicestestinginspection for quality control purposesresearch in the field of cell culture and tissue cultureconsultancy and information services relating thereto; pharmaceutical research and development advisory servicesadvisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue cultureconsultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnologyadvisory services relating thereto; contracted development of biological cell manufacturing process; scientific laboratory servicesthe cultivation or modification of hematopoietic and immune system cellsgenetically or otherwise modified cellscells which are propagatedcultivated and expanded in bioreactorscells for the purpose of tissue regeneration into living drugs
Classe 44
Medical servicescontracted cell culturing and tissue culturing for medical purposes; medical advisory servicesadvisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical servicesseparation and cultivation of body tissues and cells for medical purposes; informationadvice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medicalmedicinal and pharmaceutical consultancy; isolationcollection and preservation of blood components including cells or stem cells obtained from umbilical cord bloodbone marrowplacenta and other parts of the human bodyhematopoietic and immune system cellsgenetically or otherwise modified cellscells which are propagatedcultivated and expanded in bioreactorscells for the purpose of tissue regenerationcells of human or animal origin
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/01/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/01/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/01/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/02/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/07/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/05/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
26/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/05/2022
PUBO
PUBLISHED FOR OPPOSITION
10/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/04/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/04/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2022
ALIE
ASSIGNED TO LIE
02/03/2022
ALIE
ASSIGNED TO LIE
01/03/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
28/02/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
31/08/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
31/08/2021
CNSI
SUSPENSION INQUIRY WRITTEN
31/08/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
28/07/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/01/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/10/2020
GNSL
LETTER OF SUSPENSION E-MAILED
06/10/2020
CNSL
SUSPENSION LETTER WRITTEN
06/10/2020
DOCK
ASSIGNED TO EXAMINER
06/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/07/2020
NWAP
NEW APPLICATION ENTERED
04/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MINARIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.